• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
Trending:
  • Kashmir
  • Elections
Sunday, June 7, 2026

Daily Times

Your right to know

  • HOME
  • Latest
  • Iran-Israel war
  • Gilgit Baltistan Election
  • Pakistan
    • Balochistan
    • Gilgit Baltistan
    • Khyber Pakhtunkhwa
    • Punjab
    • Sindh
  • World
  • Editorials & Opinions
    • Editorials
    • Op-Eds
    • Commentary / Insight
    • Perspectives
    • Cartoons
    • Letters to the Editor
    • Featured
    • Blogs
      • Pakistan
      • World
      • Lifestyle
      • Culture
      • Sports
  • Business
  • Sports
  • E-PAPER
    • Lahore
    • Islamabad
    • Karachi

Reuters/Web Desk

India opens vaccination for aged 45 and above, vaccine exports to reduce

Published on: April 1, 2021 1:03 PM

india vaccination

NEW DELHI: India has decided to open vaccination drive for people aged 45 and above on Thursday as the coronavirus cases increase. The widening of vaccination drive will decrease the vaccine export from the world’s biggest maker of the drug.

India, which has the most number of registered COVID cases after Brazil and India, has so far injected 64 million doses and exported nearly as many. This has raised criticism at home as India’s per-capita vaccination figure is much lower than many countries.

The Indian government earlier said that its citizens can register for the vaccine from April 1.

India initially focused on front-like workers, the elderly and those suffering from other health conditions, unlike some richer countries that have made all their adults eligible to get inoculated.

New Delhi says it is working towards that goal, and Health Minister Harsh Vardhan tweeted that there would be no vaccine shortage in the country as it opens up the vaccination programme.

“Centre to continually replenish states’ supplies,” he said on Twitter. “Avoid overstocking and under stocking.”

India has decided to reduce the imports for now including to WHO backed global alliance, COVAX.

It is currently using the AstraZeneca vaccine and a shot developed at home by Bharat Biotech, which is struggling to step up supplies. India’s drug regulator is soon expected to approve Russia’s Sputnik V vaccine.

India has reported more than 12 million infections, including a big surge last month. Deaths stand at more than 162,400.

 

Filed Under: Top Stories, World Tagged With: covax, india vaccination

Submit a Comment




Primary Sidebar




Latest News

Mirra Andreeva wins French Open to claim first Grand Slam title

Antonelli pips Verstappen to Monaco pole

Iran World Cup squad heads to Mexico as US visa row erupts

Bosnia’s World Cup pursuit begins at a home-away-from home in the American Midwest

Football fans urge red card for coach who led Israeli club

Pakistan

All set for Gilgit-Baltistan Elections today

Mohsin Naqvi arrives in Tehran as Pakistan pushes for US-Iran deal

Lebanon army chief visits US-Iran mediator Pakistan

US strikes Iranian sites after Iran launches drones, in latest Gulf flare-up

72 held in AJK crackdown as government defends JAAC ban

More Posts from this Category

Business

PSX new IPOs deliver 47% average return, boosting investor confidence

Pakistan signs MoU with Saudi, local firms to develop Karachi maritime business district

Gold prices witness sharp decline

Gul Ahmed venture QGDC announces $230m investment to set up Pakistan’s largest data centre

SECP takes action against 36 government entities

More Posts from this Category

World

Trump claims Iran missile stockpile shrinking

Young ‘cockroaches’ hold first protest in New Delhi

Ukraine strikes key Russian military sites

More Posts from this Category




Footer

Home
Lead Stories
Latest News
Editor’s Picks

Culture
Life & Style
Featured
Videos

Editorials
OP-EDS
Commentary
Advertise

Cartoons
Letters
Blogs
Privacy Policy

Contact
Company’s Financials
Investor Information
Terms & Conditions

Facebook
Twitter
Instagram
Youtube

© 2026 Daily Times. All rights reserved.

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.